Skip to main content
. 2011 Jan;71(1):116–120. doi: 10.1111/j.1365-2125.2010.03797.x

Table 1.

Baseline characteristics of haemorrhagic stroke case control study patients

Cases n = 357 (%) Controls n = 1631 (%)
Age at index date (years)
≤30 2 (0.6) 6 (0.4)
>30–40 10 (2.8) 49 (3.0)
>40–50 26 (7.3) 129 (7.9)
>50–60 40 (11.2) 197 (12.1)
>60–70 72 (20.2) 344 (21.1)
>70–80 95 (26.6) 463 (28.4)
>80 112 (31.4) 443 (27.2)
Sex
Female 232 (65.0) 1,082 (66.3)
Male 125 (35.0) 549 (33.7)
Observation time in GPRD (quintiles)
1 (<3.4 years) 70 (19.6) 307 (18.8)
2 (3.4–6.3 years) 82 (23.0) 371 (22.8)
3 (6.3–9.9 years) 70 (19.6) 326 (20.0)
4 (9.9–13.2 years) 68 (19.1) 332 (20.4)
5 (>13.2 years) 67 (18.8) 295 (18.1)
Smoking status
Non-smoker 147 (41.2) 712 (43.7)
Current smoker 104 (29.1) 376 (23.1)
Ex-smoker 82 (23.0) 491 (30.1)
Unknown status 24 (6.7) 52 (3.2)
Alcohol consumption
Non-drinker 67 (18.8) 280 (17.2)
Ex-drinker 6 (1.7) 10 (0.6)
Current drinker (amount unknown) 6 (1.7) 33 (2.0)
<2 units/day 182 (51.0) 972 (59.6)
3–6 units/day 25 (7.0) 124 (7.6)
>6 units/day 11 (3.1) 20 (1.2)
Unknown status 60 (16.8) 192 (11.8)
BMI (kg m−2)
<20 27 (7.6) 100 (6.1)
20–25 106 (29.7) 520 (31.9)
>25 143 (40.1) 756 (46.4)
Unknown 81 (22.7) 255 (15.6)
Medical history
TIA/other stroke 101 (28.3) 147 (9.0)
Hypertension 188 (52.7) 673 (41.3)
Diabetes 54 (15.1) 209 (12.8)
Medication history
NSAIDs 267 (74.8) 1,166 (71.5)
Aspirin 182 (51.0) 592 (36.3)
Clopidogrel or dipyridamole 44 (4.3) 34 (3.6)